Alto Pharma L-Lysine 500 mg – Amino Acid Dietary Supplement, 120 Capsules
Supports protein synthesis, immune function, and overall wellness
Category: Supplements / Amino Acids & Proteins
Purpose: Amino acid supplementation for metabolism, tissue repair, and immune support
🌿 What It Is
Alto Pharma L-Lysine 500 mg is a dietary supplement formulated to support protein synthesis, tissue repair, and immune system health. Each capsule contains 500 mg of pure L-Lysine, an essential amino acid that the body cannot produce naturally. L-Lysine is vital for collagen formation, muscle maintenance, and general metabolic functions, making it ideal for adults seeking a natural supplement to support overall wellness and nutritional balance.
✅ Key Benefits
Supports protein synthesis and tissue repair
Promotes immune system health
Contributes to collagen production for skin, hair, and nails
Helps maintain muscle health and recovery
Convenient daily capsules for amino acid supplementation
🧴 Use & Dosage
Take 1–2 capsules daily, preferably with meals.
Do not exceed the recommended daily dose.
Combine with a balanced diet and healthy lifestyle for optimal results.
⚠️ Safety & Precautions
Use under medical supervision if pregnant, breastfeeding, or taking medications
Not recommended for children
Store in a cool, dry place away from sunlight
📦 Product Details
Form: Capsules
Active Ingredients: L-Lysine 500 mg per capsule
Target Group: Adults seeking amino acid supplementation, tissue repair, and immune support
Pack Size: 120 capsules
🛒 Buy Alto Pharma L-Lysine 500 mg
Support protein synthesis, tissue repair, and overall wellness naturally with Alto Pharma L-Lysine 500 mg – available now at Mypharmacy24.
🔑 SEO Keywords
Alto Pharma L-Lysine 500 mg, essential amino acid supplement, protein synthesis support, collagen production supplement, immune system booster, muscle maintenance supplement, tissue repair capsules, daily amino acid supplement, L-Lysine dietary capsules, Mypharmacy24 supplements
.






Reviews
Clear filtersThere are no reviews yet.